These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 2905151

  • 1. Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects.
    Vincent J, Sumner DJ, Reid JL.
    Br J Clin Pharmacol; 1988 Nov; 26(5):503-8. PubMed ID: 2905151
    [Abstract] [Full Text] [Related]

  • 2. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.
    Hindmarch, Shamsi Z.
    Curr Med Res Opin; 2001 Nov; 17(4):273-81. PubMed ID: 11922401
    [Abstract] [Full Text] [Related]

  • 3. Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastine.
    Mattila MJ, Aranko K, Kuitunen T.
    Br J Clin Pharmacol; 1993 Mar; 35(3):272-7. PubMed ID: 8097102
    [Abstract] [Full Text] [Related]

  • 4. Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects.
    Mattila MJ, Kuitunen T, Plétan Y.
    Eur J Clin Pharmacol; 1992 Mar; 43(2):179-84. PubMed ID: 1358620
    [Abstract] [Full Text] [Related]

  • 5. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine.
    Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Iwata R, Fujii T, Komemushi S, Ido T, Itoh M, Sasaki H, Watanabe T, Yanai K.
    Br J Clin Pharmacol; 2001 Nov; 52(5):501-9. PubMed ID: 11736858
    [Abstract] [Full Text] [Related]

  • 6. Placebo controlled comparison of acute effects of ebastine and clemastine on performance and EEG.
    Hopes H, Meuret GH, Ungethüm W, Leopold G, Wiemann H.
    Eur J Clin Pharmacol; 1992 Nov; 42(1):55-9. PubMed ID: 1347267
    [Abstract] [Full Text] [Related]

  • 7. Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance.
    Brookhuis KA, De Vries G, De Waard D.
    Br J Clin Pharmacol; 1993 Jul; 36(1):67-70. PubMed ID: 8104017
    [Abstract] [Full Text] [Related]

  • 8. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R, García-Gea C, Puntes M, Pérez J, Esbrí R, Serra C, Fortea J, Barbanoj MJ.
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [Abstract] [Full Text] [Related]

  • 9. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.
    Hindmarch I, Shamsi Z, Kimber S.
    Clin Exp Allergy; 2002 Jan; 32(1):133-9. PubMed ID: 12002730
    [Abstract] [Full Text] [Related]

  • 10. Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration.
    Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Fujii T, Komemushi S, Itoh M, Sasaki H, Watanabe T, Yanai K.
    Br J Clin Pharmacol; 2002 Mar; 53(3):296-304. PubMed ID: 11874393
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Pharmacological study of ebastine, a novel histamine H1-receptor antagonist].
    Yakuo I, Ishii K, Seto Y, Imano K, Takeyama K, Nakamura H, Karasawa T.
    Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):121-35. PubMed ID: 7511558
    [Abstract] [Full Text] [Related]

  • 14. Preclinical comparison of ebastine and other second generation H1-antihistamines.
    Yakuo I, Yabuuchi M, Ito T.
    Pharmacol Toxicol; 2001 Oct; 89(4):171-6. PubMed ID: 11881966
    [Abstract] [Full Text] [Related]

  • 15. Duration of the antihistaminic effect after discontinuation of ebastine.
    Frossard N, Vital-Durand D, Mounedji N, Valleteau A.
    Allergy; 2001 Jun; 56(6):553-7. PubMed ID: 11421903
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine.
    Van Rooij J, Schoemaker HC, Bruno R, Reinhoudt JF, Breimer DD, Cohen AF.
    Br J Clin Pharmacol; 1993 Jun; 35(6):661-3. PubMed ID: 8101096
    [Abstract] [Full Text] [Related]

  • 19. Dose-response relationship of the H1-histamine antagonist, ebastine, against histamine and methacholine-induced bronchoconstriction in patients with asthma.
    Wood-Baker R, Holgate ST.
    Agents Actions; 1990 Apr; 30(1-2):284-6. PubMed ID: 1973585
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
    Gispert J, Antonijoan R, Barbanoj M, Gich I, Garcia E, Esbrí R, Luria X.
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.